9O6H | pdb_00009o6h

The Structure of PRMT4 in complex with SGC8172


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.97 Å
  • R-Value Free: 
    0.269 (Depositor), 0.271 (DCC) 
  • R-Value Work: 
    0.232 (Depositor), 0.234 (DCC) 
  • R-Value Observed: 
    0.233 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9O6H

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Tailoring PRMT Inhibition: Shifting PRMT7 Selectivity to PRMT4 through "T-Shape" Strategy and "Linker-Specific" Preferences.

Kulkarni, A.S.Deng, Y.Nam, H.S.Zhao, T.Masal, D.P.Bush, M.M.Noinaj, N.Huang, R.

(2026) J Med Chem 69: 9977-9990

  • DOI: https://doi.org/10.1021/acs.jmedchem.5c01782
  • Primary Citation Related Structures: 
    9O37, 9O6H

  • PubMed Abstract: 

    Protein arginine methyltransferases (PRMTs) are appealing therapeutic targets due to their critical roles in regulating numerous cellular processes and their dysregulation in various diseases. Although SAH-based inhibitors effectively target PRMTs, achieving selectivity across different methyltransferases remains a significant challenge. Herein, we employed a hybrid strategy that incorporates optimal linker length and "T-shape" modifications to enhance inhibitor selectivity. Starting with a selective PRMT7 inhibitor SGC8158 (IC 50 <2.5 nM), we successfully transformed it into a selective PRMT4 inhibitor AK442 (IC 50 = 2.6 nM). This approach highlights the potential of these design strategies to tune inhibitor selectivity, facilitating the development of isoform-specific PRMT inhibitors from existing scaffolds.


  • Organizational Affiliation
    • Borch Department of Medicinal Chemistry and Molecular Pharmacology, Institute for Cancer Research, Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States.

Macromolecule Content 

  • Total Structure Weight: 152.94 kDa 
  • Atom Count: 11,424 
  • Modeled Residue Count: 1,324 
  • Deposited Residue Count: 1,324 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Histone-arginine methyltransferase CARM1
A, B, C, D
331Homo sapiensMutation(s): 0 
Gene Names: CARM1PRMT4
EC: 2.1.1.319
UniProt & NIH Common Fund Data Resources
Find proteins for Q86X55 (Homo sapiens)
Explore Q86X55 
Go to UniProtKB:  Q86X55
PHAROS:  Q86X55
GTEx:  ENSG00000142453 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ86X55
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.97 Å
  • R-Value Free:  0.269 (Depositor), 0.271 (DCC) 
  • R-Value Work:  0.232 (Depositor), 0.234 (DCC) 
  • R-Value Observed: 0.233 (Depositor) 
Space Group: P 21 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 74.67α = 90
b = 98.984β = 90
c = 206.715γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
DIALSdata scaling
DIALSdata reduction
PHASERphasing
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other privateUnited States--

Revision History  (Full details and data files)

  • Version 1.0: 2026-05-13
    Type: Initial release
  • Version 1.1: 2026-05-27
    Changes: Database references